Literature DB >> 7519453

Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.

H Walter1, S Schepensn, J Van Wauwe, M de Boer.   

Abstract

It has been well documented that cross-linking CD28 with mAb can provide a potent costimulatory signal to T cells for the production of IL-2, IL-6, IFN-gamma, GM-CSF and TNF-alpha. Much less is known about the role of the CD28 molecule in the induction of Th2-type lymphokines such as IL-4, IL-5, and IL-10. So far, only limited data are available about the secretion of IL-2, IL-6, IFN-gamma, and GM-CSF by T cells when using B7 as the natural ligand for CD28. We investigated whether B7-CD28 ligation can result in the secretion of Th2-type cytokines using 3T6 mouse fibroblasts transfected with human CD32 (Fc gamma RIIa high-responder allele, 3T6-CD32 cells) or with both CD32 and B7 (3T6-CD32/B7 cells). It was found that upon stimulation through the TCR/CD3 complex, B7-CD28 interaction not only results in the production of cytokines of the Th1 type, but also gives rise to the production of large amounts of Th-2 type cytokines such as IL-4 and IL-10. In contrast to the production of IL-2, IFN-gamma, GM-CSF, and TNF-alpha, the production of IL-4 after co-stimulation with B7-CD28 interaction was restricted to CD45RO+ memory T cells. In addition, the production of IL-4 after co-stimulation by B7-CD28 interaction was not influenced by the addition of IFN-gamma. The production of IFN-gamma was not affected by IL-4, but was slightly inhibited by IL-10.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519453

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  8 in total

1.  Naive human T cells can be a source of IL-4 during primary immune responses.

Authors:  D M Bullens; K Rafiq; A Kasran; S W Van Gool; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors.

Authors:  D M Bullens; A Kasran; X Peng; K Lorré; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

3.  Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines.

Authors:  K Rafiq; D M Bullens; A Kasran; K Lorré; J L Ceuppens; S W Van Gool
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

4.  Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.

Authors:  M Kruger; S Van Gool; X H Peng; L Coorevits; M Casteels-Van Daele; J L Ceuppens
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

5.  The inhibitory effect of pentamidine on the production of chemotactic cytokines by in vitro stimulated human blood cells.

Authors:  J Van Wauwe; F Aerts; H Van Genechten; H Blockx; W Deleersnijder; H Walter
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

6.  IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

Authors:  J B Rao; R S Chamberlain; V Bronte; M W Carroll; K R Irvine; B Moss; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

7.  Human CD81 directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulation.

Authors:  Holden T Maecker
Journal:  BMC Immunol       Date:  2003-02-19       Impact factor: 3.615

8.  Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris.

Authors:  Joanna Narbutt; Jolanta Lukamowicz; Jarosław Bogaczewicz; Anna Sysa-Jedrzejowska; Jolanta Dorota Torzecka; Aleksandra Lesiak
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.